Prominent decidualization following progestin treatment for endometrial hyperplasia and carcinoma as a mimic of large residual tumor: A cautionary tale
Objective: Progestin-based therapy is common for patients with endometrial neoplasia who desire fertility preservation, but some patients ultimately require surgery. Intraoperative assessment, which can use gross lesion size, may impact the extent of surgery performed. We sought to characterize the...
Main Authors: | Yang Hu, Ahmed N. Al-Niaimi, Alain Cagaanan, Elizabeth A. Sadowski, David M. Kushner, Paul S. Weisman, Stephanie M. McGregor |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-05-01
|
Series: | Gynecologic Oncology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352578921000527 |
Similar Items
-
Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma
by: Mu Lv, et al.
Published: (2022-12-01) -
Endometrial hyperplasia and progesterone resistance: a complex relationship
by: Mekan R. Orazov, et al.
Published: (2023-03-01) -
Aromatase inhibitor “letrozole” versus progestin “norethisterone” in women with simple endometrial hyperplasia without atypia: A prospective cohort trial
by: M. El-shamy, et al.
Published: (2012-06-01) -
Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis
by: Fengping Shao, et al.
Published: (2023-06-01) -
Identification of potential models for predicting progestin insensitivity in patients with endometrial atypical hyperplasia and endometrioid endometrial cancer based on ATAC-Seq and RNA-Seq integrated analysis
by: Jia-Li Hu, et al.
Published: (2022-08-01)